Cargando…

2572. Decreased T-Cell Response, but Appropriate Antibody Production to Tetanus Vaccine Among HIV-Exposed Uninfected Infants in Botswana

BACKGROUND: In Botswana, more than 10% of HIV-exposed, uninfected infants (HEU) are hospitalized or die in the first 6 months of life, largely due to infectious causes. Vaccine responses can act as a marker of the immune response to infectious antigens. Previous studies of vaccine responses in HEU h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Christiana, Moraka, Natasha, Ibrahim, Maryanne, Moyo, Sikhulile, Mayondi, Gloria, Kammerer, Betsy, Leidner, Jean, Gaseitsiwe, Simani, Shapiro, Roger, Lockman, Shahin, Weinberg, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252798/ http://dx.doi.org/10.1093/ofid/ofy209.180

Ejemplares similares

No Difference in Antibody Responses to Tetanus Vaccine Among HIV-Exposed and -Unexposed Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2017)

2529. Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations with 24-Month Growth and Neurodevelopment
por: Moraka, Natasha Onalenna, et al.
Publicado: (2019)

Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations With 24-Month Growth and Neurodevelopment
por: Moraka, Natasha O, et al.
Publicado: (2020)

Unintended pregnancy, contraceptive use, and childbearing desires among HIV-infected and HIV-uninfected women in Botswana: across-sectional study
por: Mayondi, Gloria K., et al.
Publicado: (2016)

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana
por: Mbangiwa, Tshepiso, et al.
Publicado: (2018)

Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana
por: Baruti, Kabo, et al.
Publicado: (2020)

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
por: Rantshabeng, Patricia S., et al.
Publicado: (2017)

B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine
por: Weinberg, Adriana, et al.
Publicado: (2018)

High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana
por: Baruti, Kabo, et al.
Publicado: (2023)

Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana
por: Seatla, Kaelo K., et al.
Publicado: (2021)

Maternal biomarkers of endothelial dysfunction and pregnancy outcomes in women with and without HIV in Botswana
por: Masheto, Gaerolwe, et al.
Publicado: (2023)

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay
por: Rantshabeng, Patricia, et al.
Publicado: (2019)

Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2023)

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
por: Moraka, Natasha O., et al.
Publicado: (2023)

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use
por: Maruapula, Dorcas, et al.
Publicado: (2023)

Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls
por: Mosepele, Mosepele, et al.
Publicado: (2017)

Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2021)

Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2014)

HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

HIV-exposed children account for more than half of 24-month mortality in Botswana
por: Zash, Rebecca, et al.
Publicado: (2016)

Lack of HIV RNA test result is a barrier to breastfeeding among women living with HIV in Botswana
por: Mayondi, Gloria Katuta, et al.
Publicado: (2021)

Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2021)

High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana
por: Phinius, Bonolo B, et al.
Publicado: (2023)

Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana
por: Bhebhe, Lynnette, et al.
Publicado: (2022)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
por: Bareng, Ontlametse T., et al.
Publicado: (2022)

Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2016)

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †
por: Seatla, Kaelo K., et al.
Publicado: (2021)

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
por: Mokaleng, Baitshepi, et al.
Publicado: (2023)

Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2018)

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana
por: Kotokwe, Kenanao, et al.
Publicado: (2023)

Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana
por: Mogashoa, Tuelo, et al.
Publicado: (2019)

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana
por: Ryan, Kathleen, et al.
Publicado: (2017)

Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana
por: Powis, Kathleen M, et al.
Publicado: (2017)

Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)

HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long–term antiretroviral therapy in Botswana
por: Mosepele, Mosepele, et al.
Publicado: (2018)

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana
por: N’Guessan, Kombo F, et al.
Publicado: (2017)

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2020)

Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana
por: Maruapula, Dorcas, et al.
Publicado: (2021)

Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2i5llc5hsinb0lv4kl9vqlis0n